Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol-Reference-Cited by-同舟云学术

Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol

Published:2014-01-30 Issue:3 Volume:165 Page:392-401
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Gandemer Virginie¹,Pochon Cécile²,Oger Emmanuel³,Dalle Jean-Hugues H.⁴,Michel Gérard⁵,Schmitt Claudine²,de Berranger Eva⁶,Galambrun Claire⁷,Cavé Hélène⁸,Cayuela Jean-Michel⁹,Grardel Nathalie¹⁰,Macintyre Elizabeth¹¹,Margueritte Geneviève¹²,Méchinaud Françoise¹³,Rorhlich Pierre¹⁴,Lutz Patrick¹⁵,Demeocq François¹⁶,Schneider Pascale¹⁷,Plantaz Dominique¹⁸,Poirée Marilyne¹⁹,Bordigoni Pierre²

Affiliation:

1. Department of Paediatric Haematology/Oncology; University Hospital of Rennes; Rennes France

2. Department of Paediatric Haematology/oncology; University Hospital of Nancy; Nancy France

3. Clinical Pharmacology Department; Pharmacoepidemiology Team; University Hospital of Rennes; Rennes France

4. Department of Paediatric Haematology; University Hospital of Robert Debré; Paris France

5. Department of Paediatric Haematology; University Hospital of La Timone; Marseille France

6. Department of Paediatric Haematology/Oncology; University Hospital of Jeanne de Flandre; Lille France

7. Department of Paediatric Haematology; Hospices Civils de Lyon; Lyon France

8. Department of Genetics; University Hospital of Robert Debré and Paris-Diderot University; Paris France

9. Laboratory of Haematology; University Hospital of St Louis; Paris France

10. Laboratory of Haematology; University Hospital of Calmette; Lille France

11. Laboratory of Haematology; University Hospital of Necker; Paris France

12. Department of Paediatric Haematology/Oncology; University Hospital of Villeneuve; Montpellier France

13. Department of Paediatric Haematology/Oncology; University Hospital of Nantes; Nantes France

14. Department of Paediatric Haematology/Oncology; University Hospital of Besançon; Besançon France

15. Department of Paediatric Haematology/Oncology; University Hospital of Hautepierre; Strasbourg France

16. Department of Paediatric Haematology/oncology; University Hospital of Clermont-Ferrand; Clermont-Ferrand France

17. Department of Paediatric Haematology; University Hospital of Rouen; Rouen France

18. Department of Paediatric Haematology/oncology; University Hospital of La Tronche; Grenoble France

19. Department of Paediatric Haematology/oncology; University Hospital of Archet II; Nice France

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12749/fullpdf

Reference45 articles.

1. Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL;Bader;Leukemia,2002

2. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group;Bader;Journal of Clinical Oncology,2009

3. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study;Balduzzi;Lancet,2005

4. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study;Biondi;The Lancet Oncology,2012

5. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study;Borowitz;Blood,2008

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Clinical and Genetic Features of ETV6/RUNX1-like Acute Lymphoblastic Leukemia in Pediatric: A Multicenter Retrospective Study;2024-03-13

2. The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia;Best Practice & Research Clinical Haematology;2023-09

3. Effects of isolated central nervous system involvement evaluated by multiparameter flow cytometry prior to allografting on outcomes of patients with acute lymphoblastic leukemia;Frontiers in Oncology;2023-05-10

4. Comparisons of Long-Term Survival and Safety of Haploidentical Hematopoietic Stem Cell Transplantation After CAR-T Cell Therapy or Chemotherapy in Pediatric Patients With First Relapse of B-Cell Acute Lymphoblastic Leukemia Based on MRD-Guided Treatment;Frontiers in Immunology;2022-06-06

5. A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study;Frontiers in Oncology;2022-03-29